First experience in Switzerland in Phe508del homozygous cystic fibrosis patients with end-stage pulmonary disease enrolled in a lumacaftor-ivacaftor therapy trial – preliminary results. Swiss Medical Weekly, [S. l.], v. 148, n. 0708, p. w14593, 2018. DOI: 10.4414/smw.2018.14593. Disponível em: https://smw.ch/index.php/smw/article/view/2449. Acesso em: 25 oct. 2025.